Our ex vivo lentiviral gene therapy pipeline includes clinical programs in Fabry disease, Gaucher disease type 1 and cystinosis, as well as preclinical ...
https://www.google.com/url?rct=j&sa=t&url=https://www.businesswire.com/news/home/20210205005489/en/AVROBIO-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNFt9IMkkZs_-FgbKtcpnP3RykGqfA
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.